Compare VERA & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | KLIC |
|---|---|---|
| Founded | 2016 | 1951 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 2021 | 2004 |
| Metric | VERA | KLIC |
|---|---|---|
| Price | $39.90 | $68.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $80.56 | $54.67 |
| AVG Volume (30 Days) | 835.9K | ★ 844.7K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.24% |
| EPS Growth | N/A | ★ 100.32 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $654,081,000.00 |
| Revenue This Year | N/A | $45.04 |
| Revenue Next Year | $445.28 | $11.95 |
| P/E Ratio | ★ N/A | $205.77 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.53 | $26.63 |
| 52 Week High | $56.05 | $77.50 |
| Indicator | VERA | KLIC |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 53.85 |
| Support Level | $19.84 | $67.31 |
| Resistance Level | $56.05 | $72.90 |
| Average True Range (ATR) | 1.86 | 2.89 |
| MACD | -0.21 | -1.00 |
| Stochastic Oscillator | 16.45 | 31.39 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Kulicke & Soffa Industries Inc. is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments, which include Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.